CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology

Circulation. 1990 Mar;81(3):1123-7. doi: 10.1161/01.cir.81.3.1123.
No abstract available

Publication types

  • Clinical Trial
  • Consensus Development Conference
  • Multicenter Study
  • Randomized Controlled Trial
  • Review

MeSH terms

  • Anilides / adverse effects
  • Anilides / therapeutic use
  • Anti-Arrhythmia Agents / adverse effects
  • Anti-Arrhythmia Agents / therapeutic use*
  • Arrhythmias, Cardiac / drug therapy*
  • Cardiac Complexes, Premature / drug therapy
  • Double-Blind Method
  • Encainide
  • Flecainide / adverse effects
  • Flecainide / therapeutic use
  • Humans
  • Moricizine
  • Multicenter Studies as Topic
  • Phenothiazines / therapeutic use
  • Randomized Controlled Trials as Topic

Substances

  • Anilides
  • Anti-Arrhythmia Agents
  • Phenothiazines
  • Moricizine
  • Flecainide
  • Encainide